Open-House-Biologika-Rabattverträge 2025-24 - Ranibizumab
openRead the notice at vergabe-de ↗
Value
unstated
Published
26 Sept 2025
Deadline
31 Oct 2026, 22:58 GMT · 7d left · as published, verify on the notice
Type
opportunity
33600000 · Medical equipment, pharmaceuticals & personal careDE600DE501
Description
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Ranibizumab im Rahmen eines Open-House-Verfahrens.
Key facts
- Reference
- OB-2025-24
- Lots
- 1
- Contact
- DZEM@tk.de+49 4069094-040
- Bids opened
- 31 Oct 2026, 22:59 GMT
- Regime
- publicSector
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- Calendar export — the deadline as a calendar file
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- vergabe-de
- Notice id
- c41e34fc-f3d7-482f-8089-f5bfab21f33f
- OCID
- ocds-mnwr74-3b5328fa-d70d-4aca-947f-45f9cb5aaa54
- First seen
- 23 Aug 2026
- Last updated
- 23 Aug 2026
Licence CC0 1.0 public domain dedication ↗
Source: Bekanntmachungsservice (oeffentlichevergabe.de), Beschaffungsamt des BMI — CC0 1.0.
View at source ↗
GET /api/v1/tenders/9ce3fd11-4726-4111-a1ea-73a099be2b32The source notice is authoritative — verify deadlines and documents there before bidding.